AstraZeneca (AZN) Event July 25, 2022, 10:51 UTC (85% Positive) AstraZeneca (AZN) Announces Clinical Development Update (Form 6-K) Full text
Register to leave comments News bot Oct. 18, 2025, 6:02 p.m. 🌍 AstraZeneca (AZN) - Form 6-K Filing Filing Date: 2022-07-25 Accepted: 2022-07-25 06:51:23 Event Type: Clinical Trial Update Event Details: No summary available 💼 Business Developments: ❌ Partnership/Collaboration: Not reported✅ Acquisition Activity❌ Licensing Agreement: Not reported✅ Regulatory Milestone❌ Leadership Updates: Not reported 📞 Contact Information: Media Contact: s, click here. References 1. Ultomiris (ravulizumab-cwvz) US prescribing informa
🌍 AstraZeneca (AZN) - Form 6-K Filing
Filing Date: 2022-07-25
Accepted: 2022-07-25 06:51:23
Event Type: Clinical Trial Update
Event Details:
💼 Business Developments:
📞 Contact Information: